the Ajinomoto Group Global Website
Stories
Back
Close
About Us
Science and Health
Products and Innovation
About Us
About the Ajinomoto Group
Investors
Nutrition
Human Capital
Science and Health
Amino Acids
Umami
MSG (Monosodium Glutamate)
Umami Recipes
Products and Innovation
Our Businesses
Our Brands
Quality Assurance
Innovation
Stories
Sustainability
Press Releases
Contact Us
Language
EN
EN
AR
ES
FR
KO
PT
TH
VI
ZH-CN
ZH-TW
About the Ajinomoto Group
Investors
Nutrition
Human Capital
Amino Acids
Umami
MSG (Monosodium Glutamate)
Umami Recipes
Our Businesses
Our Brands
Quality Assurance
Innovation
Home
Media
Press Releases
Ajinomoto Co., Inc. Enters Licensing Agreement with Astellas Pharma Inc. for Biopharmaceutical Development and Manufacturing Technology
Press Releases
Ajinomoto Co., Inc. Enters Licensing Agreement with Astellas Pharma Inc. for Biopharmaceutical Development and Manufacturing Technology
Press Releases
2026
2025
2024
2023
2022
2021
2020
2019
2018
